NEWS
-
PR
Phase II clinical trial begins for polycystic kidney disease drug candidate identified by iPS cell-based drug discovery
-
PR
Rege Nephro exhibited at “JAPAN KYOTO TRADE EXIBITION 2024” held in Dubai, UAE
-
PR
Rege Nephro exhibited at “InnoVision from Kyoto University: Seeing the Future through Innovation” held in Singapore
-
PR
A research group of Senior Researcher Hiraku Tsujimoto and Professor Kenji Osafune have developed a selective induction method of renal interstitial progenitor cells from human iPS cells and successfully created kidney tissues with glomerular mesangium structures, and published a research paper about that...
-
PR
Rege Nephro announces joint research agreement with CiRA Kyoto University and Abu Dhabi Stem Cells Center Aiming to develop new treatments for diabetes through collaborative research using iPS cells
-
Phase II clinical trial begins for polycystic kidney disease drug candidate identified by iPS cell-based drug discovery
-
Rege Nephro exhibited at “JAPAN KYOTO TRADE EXIBITION 2024” held in Dubai, UAE
-
Rege Nephro exhibited at “InnoVision from Kyoto University: Seeing the Future through Innovation” held in Singapore
-
A research group of Senior Researcher Hiraku Tsujimoto and Professor Kenji Osafune have developed a selective induction method of renal interstitial progenitor cells from human iPS cells and successfully created kidney tissues with glomerular mesangium structures, and published a research paper about that...
-
Rege Nephro announces joint research agreement with CiRA Kyoto University and Abu Dhabi Stem Cells Center Aiming to develop new treatments for diabetes through collaborative research using iPS cells
-
Our business was introduced in Science Japan, an online magazine published by JST.
-
An article about Toshihiro Ishikiriyama, our president, was published in AnswersNews, serial column: Venture Round Visit Report.
-
Featured in Nikkei newspaper, its electronic version, Asahi Shimbun DIGITAL and many other media.
-
Published in the Nikkei newspaper and the electronic version.